EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) ON STRIATAL TYROSINE-HYDROXYLASE AND TRYPTOPHAN-HYDROXYLASE IN RAT

被引:17
作者
MATSUDA, LA [1 ]
SCHMIDT, CJ [1 ]
HANSON, GR [1 ]
GIBB, JW [1 ]
机构
[1] UNIV UTAH,DEPT BIOCHEM PHARMACOL & TOXICOL,SALT LAKE CITY,UT 84112
关键词
D O I
10.1016/0028-3908(86)90247-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:249 / 255
页数:7
相关论文
共 32 条
[1]   REPEATED ADMINISTRATION OF N-METHYL-4-PHENYL-1,2,5,6-TETRAHYDROPYRIDINE TO RATS IS NOT TOXIC TO STRIATAL DOPAMINE NEURONS [J].
BOYCE, S ;
KELLY, E ;
REAVILL, C ;
JENNER, P ;
MARSDEN, CD .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (11) :1747-1752
[2]  
BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
[3]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[4]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[5]  
CHIUEH CC, 1984, EUR J PHARMACOL, V100, P189, DOI 10.1016/0014-2999(84)90221-8
[6]   CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254
[7]   INHIBITION OF DOPAMINE UPTAKE BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE, A CAUSE OF PARKINSONISM [J].
DENTON, T ;
HOWARD, BD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 119 (03) :1186-1190
[8]   ACUTE ADMINISTRATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) REDUCES DOPAMINE AND SEROTONIN BUT ACCELERATES NOREPINEPHRINE METABOLISM IN THE RAT-BRAIN - EFFECT OF CHRONIC PRETREATMENT WITH MPTP [J].
ENZ, A ;
HEFTI, F ;
FRICK, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 101 (1-2) :37-44
[9]  
FISCHMAN MW, 1975, BEHAVIORAL TOXICOLOG, V5, P375
[10]  
GIBB JW, 1982, PSYCHOBIOLOGY SCHIZO, P173